The top 20 drugs by worldwide sales in 2020 Fierce Pharma

The drug generated $7.12 billion in 2019, enough for the No. 8 spot, but as biosim challengers gained steam, sales fell to $5.32 billion in 2020. Avastin ended up …

Actived: Just Now


The top 10 drugs losing US exclusivity in 2022 Fierce Pharma

(4 days ago) Aside from BMS, AbbVie is losing U.S. exclusivity on a pair of eye drugs in 2022. Restasis, a drug inherited in its Allergan buyout, is facing new copycats from …

Category:  Health Go Now

The top 10 most-advertised prescription drug brands

(1 days ago) The big push at the top resulted in 5 drugs surpassing the $200 million mark in spending in 2014, versus just two that crossed that threshold in 2013. The …

Category:  Health Go Now

Top 10 most anticipated drug launches of 2022 Fierce Pharma

(2 days ago) Overall, it’s the Alzheimer's drug prospects that dominate the sales charts as a group, with Lilly’s donanemab worth potentially $6 billion by 2026 and Roche’s rival gantenerumab set to take

Category:  Health Go Now

The 10 most-anticipated drug launches of 2021 Fierce Pharma

(2 days ago) The 10 most-anticipated drug launches of 2021. By Beth Snyder Bulik, Angus Liu Feb 22, 2021 12:00am. drug launch argenx Biogen Bristol Myers Squibb. Share. Fierce …

Category:  Health Go Now

The top 10 drug launches since 2017 Fierce Pharma

(5 days ago) But the entire HCV market shrank, and Gilead's Epclusa franchise brought in $1.97 billion in 2019, flat over the prior year. Its archrival, AbbVie’s Mavyret, the top drug on our list, saw the

Category:  Health Go Now

The Path to a More Data-Driven Understanding of the Specialty …

(2 days ago) Pharmaceutical companies continue to aggressively roll out new specialty drugs to provide more effective treatment of complex and chronic conditions. The global market for these treatments was

Category:  Pharmaceutical Go Now

As Lilly gears up for key 2022 launches, Trulicity, Taltz and more

(1 days ago) While Eli Lilly's Alzheimer's disease hopeful donanemab stole most of the headlines for the drugmaker Tuesday, the company's stable of approved drugs continued on their growth path.

Category:  Health Go Now

The top 10 antibody-drug conjugate contenders in 2021

(Just Now) Other add-on partners that it’s testing include AbbVie-shared Venclexta, and CD20xCD3 bispecific antibodies mosunetuzumab and glofitamab. Welford’s 2021 sales projection for Roche’s two ADCs

Category:  Health Go Now

The top 20 pharma companies by 2019 revenue Fierce Pharma

(3 days ago) Takeda. 2019 revenue: JPY 3,236.7 billion ($29.88 billion) 2018 revenue: JPY 1,781.0 billion ($16.44 billion) Headquarters: Tokyo, Japan. This is the first time Takeda—or any Asian pharma—has

Category:  Health Go Now

Top 10 all-star drugs in 2024: Humira's captain, but who else …

(1 days ago) But despite the competition, Herceptin ($114.9 billion) will move up a couple of notches to eighth place in 2024. And Avastin ($114.3 billion) will move onto the 2024 list in ninth place, as

Category:  Health Go Now

The top 20 drugs by global sales in 2019 Fierce Pharma

(7 days ago) Prevnar hit $5.95 billion in sales in 2019, making it Pfizer's best-selling solo medicine—unlike blood thinner Eliquis, which is co-marketed with Bristol Myers Squibb. In 2026, the year Prevnar

Category:  Health Go Now

The top 15 blockbuster patent expirations coming this decade

(5 days ago) 2020 sales: $9.2 billion. Key patent expirations: 2027 to 2029. Generic versions of Bristol Myers Squibb and Pfizer’s blockbuster Eliquis have already scored tentative FDA nods. But thanks to

Category:  Health Go Now

The top 10 drug launches of 2019 Fierce Pharma

(9 days ago) In addition to Tremfya and Ilumya, Skyrizi is also up against the IL-17s—Novartis’ Cosentyx, Eli Lilly’s Taltz and Valeant’s Siliq—as well as IL-12/23 drug Stelara from J&J, Celgene

Category:  Health Go Now

The top 20 pharma companies by 2020 revenue Fierce Pharma

(3 days ago) Together, the $11.5 billion in global sales in 2020 bested last year’s revenues from Regeneron, Alexion, Bausch, Merck KGaA’s pharma outfit and other midsized pharmaceutical companies

Category:  Pharmaceutical Go Now

The 20 most expensive pharmacy drugs in the U.S. in 2020, from …

(7 days ago) And GoodRx's latest ranking of the country's costliest drugs include brands new and old. The 20 most expensive pharmacy drugs in the U.S. in 2020, from …

Category:  Pharmacy Go Now

The top 20 drugs in 2020--worldwide sales Fierce Pharma

(7 days ago) Forecasting drug sales is a tricky business; just ask any biopharma CEO who has overpromised and underdelivered. The people who make it their …

Category:  Health Go Now

The top 10 most-expensive meds in the U.S.—and they're not the …

(3 days ago) Sanofi’s Lumizyme for Pompe disease ranks No. 8 at $630,630 per year. Takeda’s Takhzyro rounds out the top 10 with an annual cost of $573,820. Picked up …

Category:  Health Go Now

'The Top Line' podcast: The aftermath of Roche’s failed TIGIT, Big

(1 days ago) Anti-TIGIT drugs were once hailed as the future of immuno-oncology. | This week on "The Top Line," we discuss what's left in the wake of Roche’s failed high-risk bet …

Category:  Health Go Now

From Novartis, Bristol MS meds to new ADCs, here are 2020's …

(8 days ago) Every year, new drugs enter the market, but only a select few come bearing blockbuster potential. For the 2020 crop, 11 are expected to cross …

Category:  Health Go Now

Top 20 generic molecules worldwide Fierce Pharma

(8 days ago) The big news in generic drugs in the last couple of years has been all of the marquee brands that are getting their tails kicked by generic competition. The best example is the loss of the patent

Category:  Health Go Now

Novartis halts US production for cancer drugs Lutathera, Pluvicto

(1 days ago) Novartis has temporarily stopped producing its neuroendocrine tumor therapy Lutathera as well as its freshly FDA-approved prostate cancer drug Pluvicto at facilities in Ivrea, Italy, and Millburn

Category:  Cancer Go Now

2021 drug approvals: In a year dominated by COVID, biopharma …

(9 days ago) Each year, many scientists and other experts working in the biopharma industry see years of their work culminate in FDA approvals. With the COVID-19 …

Category:  Health Go Now

The top 10 drugmakers of 2024 Fierce Pharma

(6 days ago) Together, the top 10 drugmakers in 2024—as outlined in a recent report from EvaluatePharma—will hold 35% of the total biopharma market share, or more than $420 billion in sales that year

Category:  Health Go Now

The top 10 drugs losing U.S. exclusivity in 2021 Fierce Pharma

(4 days ago) The leading AMD drug on the market, Regeneron’s Eylea, pulled $4.95 billion in 2020, a 7% increase from the prior year despite challenges associated …

Category:  Health Go Now

The top 10 cancer drug makers of 2024 Fierce Pharma

(3 days ago) Look at 2017. The trio of drugmakers together held a 45.8% share of the market, with longtime cancer leader Roche controlling 26.4% all on its own. In 2024, though, market intelligence firm

Category:  Cancer Go Now

AbbVie's new migraine meds could each pull in $2B at peak …

(7 days ago) With two of the most promising drugs in the class—Ubrelvy and Qulipta—AbbVie is set to benefit. AbbVie's new migraine meds could each pull in $2B at …

Category:  Health Go Now

The top 15 pharma companies by 2026 sales Fierce Pharma

(1 days ago) Roche. Estimated 2026 sales: $61.9 billion. 2019 sales: $48.2 billion. 2019-26 CAGR: 3.62%. Roche’s making the top of pharma’s 2026 sales ranking is …

Category:  Health Go Now

After high-profile US rejection for roxadustat, Astellas touts its

(8 days ago) While anemia med roxadustat’s U.S. fate remains in limbo, FibroGen partner Astellas is trumpeting data that could help clear the air around its disputed safety profile.

Category:  Health Go Now

Regeneron, GlaxoSmithKline COVID-19 antibodies in high demand …

(6 days ago) Despite the high-profile success of COVID-19 antibodies as a treatment for former president Donald Trump, it’s taken a while for the drugs to really catch on. | …

Category:  Health Go Now

Sanofi's Xenpozyme, Lilly's Olumiant among batch of new EU …

(Just Now) Following the FDA’s familiar playbook with a flurry of Friday afternoon approvals, the European Medicines Agency has endorsed several new drugs, including Sanofi’s Xenpozyme, an …

Category:  Health Go Now

Regeneron's COVID-19 drug delayed for full FDA approval

(9 days ago) Just as Regeneron’s COVID-19 antibody combination, REGEN-COV, is sidelined in the U.S. thanks to omicron, the drug has hit a hiccup on its quest for a …

Category:  Health Go Now

Big Pharma join coalition to improve access to cancer drugs in …

(8 days ago) Several large pharma companies have joined hands with global health organizations in a new partnership that aims to improve access to essential cancer medicines in poorer nations.

Category:  Cancer medicine,  Health,  Cancer Go Now

The 20 most expensive pharmacy drugs in 2018, featuring names …

(8 days ago) Rounding out the top 15 are Gilead's Sovaldi, which costs $28,000 per month, and AbbVie's Viekira Pak at $27,773 per month. The drugs were the …

Category:  Health Go Now

Feds probe ring of counterfeit HIV meds targeting Gilead

(Just Now) In January, when Gilead revealed that it h | The Department of Justice is said to be investigating reports of distributors and pharmacies selling counterfeit versions of HIV drugs from several

Category:  Health Go Now

ICER says Pfizer's Paxlovid, Merck's molnupiravir both cost …

(6 days ago) Weighing three outpatient treatments for COVID-19, drug cost watchdog ICER has determined that Pfizer’s Paxlovid, Merck and Ridgeback Biotherapeutics’ molnupiravir and generic fluvoxamine all

Category:  Health Go Now

FDA probes TG Therapeutics' Ukoniq over potential for elevated …

(6 days ago) Hyped as a safer version of other drugs in its class upon its approval last February, TG Therapeutics’ Ukoniq FDA probes TG Therapeutics' Ukoniq …

Category:  Health Go Now

Amgen's COVID-19 manufacturing deal with Lilly helped …

(8 days ago) As Amgen struggles to find growth from its own drugs, the company got a nice late-2021 revenue bump from its manufacturing partnership with Eli Lilly. | …

Category:  Health Go Now

Top Categories

Popular Searched

 › hwp sign in

 › Purple pharmacy algodones mail order

 › State farm medicare supplement portal claim status

 › Myuhcmedicare health & wellness products catalog

 › Urgent care omni place in seneca sc

 › Physicians of family medicine oxbridge

 › Cms sole community hospital reimbursement

 › Largest for profit hospital companies

 › Miami dade medical examiner website

 › Healthcare gov account sign in

 › Vidant home health and hospice

 › Convenient care joplin mo

 › Roanoke emergency vet hospital

 › Medical recliners near me

 › Usc find a doctor

Recently Searched

 › Pharmacy tech license test

 › Univ of tennessee hospital knoxville

 › Iv drug users facts

 › Aarp medicare drug plan 2021

 › Medicaid national drug rebate agreement

 › Mayo lake city hospital

 › Medical sales job description

 › Iin health history form

 › Drug mart york rd parma

 › Pharmacy school us ranking

 › Shoppers drug kelowna bc

 › Ncpdp lookup for pharmacy

 › Circle health urgent care

 › Drugs a to z list

 › Medicare part d formulary 2021 list